Rascas 1.5mg Injection
Prescription Required
Product introduction
Rascas 1.5mg Injection is used in the treatment of high uric acid due to chemotherapy. It lowers uric acid levels in the blood which helps prevent kidney damage in cancer patients.
It is uricolytic drug
It is uricolytic drug
Uses of Rascas Injection
- Treatment of High uric acid due to chemotherapy
Benefits of Rascas Injection
In Treatment of High uric acid due to chemotherapy
Certain types of cancer, like kidney or bladder cancer, may cause high levels of uric acid due to ongoing cancer chemotherapy. This can worsen patient health conditions and also lead to more serious health issues. Rascas 1.5mg Injection helps reduce these high levels of uric acid and prevents further complications. This will ensure speedy recovery and improve your quality of life. Follow your doctor’s instructions and let your doctor know if you have any concerns.
Side effects of Rascas Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Rascas
- Nausea
- Headache
- Vomiting
- Rash
- Hives
- Fever
- Diarrhea
How to use Rascas Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Rascas 1.5mg Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Rascas 1.5mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Rascas 1.5mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
CONSULT YOUR DOCTOR
It is not known whether Rascas 1.5mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
SAFE IF PRESCRIBED
Rascas 1.5mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Rascas 1.5mg Injection may not be needed in these patients. Please consult your doctor.
Liver
SAFE IF PRESCRIBED
Rascas 1.5mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Rascas 1.5mg Injection may not be needed in these patients. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Rascas 1.5mg Injection
₹59.0/Injection
Rasburnat Injection
Natco Pharma Ltd
₹8800/injection
14815% costlier
Rasbelon Injection
Celon Laboratories Ltd
₹8100/injection
13629% costlier
Rasby Injection
Intas Pharmaceuticals Ltd
₹8800/injection
14815% costlier
Rasuric 1.5mg Injection
Aureate Healthcare Pvt Ltd
₹7126/injection
11978% costlier
Quick tips
- Rascas 1.5mg Injection lowers uric acid levels in the blood which helps prevent kidney damage in cancer patients.
- It is injected slowly into a vein.
- It is given once a day, for up to 7 days.
- Your doctor may get regular blood tests doneto check the levels of uric acid during treatment with this medicine.
- Inform your doctor immediately if you experience difficulty breathing, chest pain, swelling in the face and throat, itching, or dizziness.
Fact Box
Chemical Class
Recombinant Xanthine Oxidase Enzyme
Habit Forming
No
Therapeutic Class
BLOOD RELATED
Action Class
Uricolytic agent- Chemotherapy
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 998.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1201-202.
- Rasburicase. Guildford, Surrey: SANOFI; 2001 [revised 07 Jul. 2016]. [Accessed 25 Jan. 2019] (online) Available from:
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Rasburicase. [Updated 2018 Dec 3]. [Accessed 18 Feb. 2020] (online) Available from:
Marketer details
Name: Sayre Therapeutics Pvt Ltd
Address: 91, 3rd Floor, G. R. Square, Amarjyothi Nagar HBCS Layout, Inner Ring Road, Domlur, Bangalore 560071, Karnataka, India.
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹59
Inclusive of all taxes
1.0 Injection in 1 vial
SOLD OUT
Notify me